FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588396622> ?p ?o ?g. }

• W2588396622 endingPage "155" @default.
• W2588396622 startingPage "145" @default.
• W2588396622 abstract "Hypertrophic cardiomyopathy (HCM) is often caused by sarcomere gene mutations, resulting in left ventricular hypertrophy (LVH), myocardial fibrosis, and increased risk of sudden cardiac death and heart failure. Studies in mouse models of sarcomeric HCM demonstrated that early treatment with an angiotensin receptor blocker (ARB) reduced development of LVH and fibrosis. In contrast, prior human studies using ARBs for HCM have targeted heterogeneous adult cohorts with well-established disease. The VANISH trial is testing the safety and feasibility of disease-modifying therapy with an ARB in genotyped HCM patients with early disease.A randomized, placebo-controlled, double-blind clinical trial is being conducted in sarcomere mutation carriers, 8 to 45 years old, with HCM and no/minimal symptoms, or those with early phenotypic manifestations but no LVH. Participants are randomly assigned to receive valsartan 80 to 320 mg daily (depending on age and weight) or placebo. The primary endpoint is a composite of 9 z-scores in domains representing myocardial injury/hemodynamic stress, cardiac morphology, and function. Total z-scores reflecting change from baseline to final visits will be compared between treatment groups. Secondary endpoints will assess the impact of treatment on mutation carriers without LVH, and analyze the influence of age, sex, and genotype.The VANISH trial is testing a new strategy of disease modification for treating sarcomere mutation carriers with early HCM, and those at risk for its development. In addition, further insight into disease mechanisms, response to therapy, and phenotypic evolution will be gained." @default.
• W2588396622 created "2017-02-24" @default.
• W2588396622 creator A5000020632 @default.
• W2588396622 creator A5005820638 @default.
• W2588396622 creator A5027213857 @default.
• W2588396622 creator A5033742702 @default.
• W2588396622 creator A5043533532 @default.
• W2588396622 creator A5044740469 @default.
• W2588396622 creator A5052863636 @default.
• W2588396622 creator A5054197629 @default.
• W2588396622 creator A5054830306 @default.
• W2588396622 creator A5076205303 @default.
• W2588396622 creator A5082899595 @default.
• W2588396622 creator A5083767342 @default.
• W2588396622 date "2017-05-01" @default.
• W2588396622 modified "2023-10-17" @default.
• W2588396622 title "The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial" @default.
• W2588396622 cites W101757858 @default.
• W2588396622 cites W1826116083 @default.
• W2588396622 cites W1964248172 @default.
• W2588396622 cites W1966978470 @default.
• W2588396622 cites W1978284123 @default.
• W2588396622 cites W1978660097 @default.
• W2588396622 cites W1983283029 @default.
• W2588396622 cites W2019476174 @default.
• W2588396622 cites W2036779262 @default.
• W2588396622 cites W2038198688 @default.
• W2588396622 cites W2051978340 @default.
• W2588396622 cites W2077738720 @default.
• W2588396622 cites W2087398999 @default.
• W2588396622 cites W2100906399 @default.
• W2588396622 cites W2124216337 @default.
• W2588396622 cites W2128077735 @default.
• W2588396622 cites W2130120331 @default.
• W2588396622 cites W2145794294 @default.
• W2588396622 cites W2147922516 @default.
• W2588396622 cites W2149422196 @default.
• W2588396622 cites W2152350731 @default.
• W2588396622 cites W2155965977 @default.
• W2588396622 cites W2158480686 @default.
• W2588396622 cites W2160600028 @default.
• W2588396622 cites W2169617161 @default.
• W2588396622 cites W2174602966 @default.
• W2588396622 cites W2219899519 @default.
• W2588396622 cites W2271175958 @default.
• W2588396622 cites W2320983896 @default.
• W2588396622 cites W2507227767 @default.
• W2588396622 cites W2557981253 @default.
• W2588396622 cites W2607031541 @default.
• W2588396622 cites W2616302857 @default.
• W2588396622 cites W3186521396 @default.
• W2588396622 doi "https://doi.org/10.1016/j.ahj.2017.02.008" @default.
• W2588396622 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5586211" @default.
• W2588396622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28454798" @default.
• W2588396622 hasPublicationYear "2017" @default.
• W2588396622 type Work @default.
• W2588396622 sameAs 2588396622 @default.
• W2588396622 citedByCount "40" @default.
• W2588396622 countsByYear W25883966222016 @default.
• W2588396622 countsByYear W25883966222017 @default.
• W2588396622 countsByYear W25883966222018 @default.
• W2588396622 countsByYear W25883966222019 @default.
• W2588396622 countsByYear W25883966222020 @default.
• W2588396622 countsByYear W25883966222021 @default.
• W2588396622 countsByYear W25883966222022 @default.
• W2588396622 countsByYear W25883966222023 @default.
• W2588396622 crossrefType "journal-article" @default.
• W2588396622 hasAuthorship W2588396622A5000020632 @default.
• W2588396622 hasAuthorship W2588396622A5005820638 @default.
• W2588396622 hasAuthorship W2588396622A5027213857 @default.
• W2588396622 hasAuthorship W2588396622A5033742702 @default.
• W2588396622 hasAuthorship W2588396622A5043533532 @default.
• W2588396622 hasAuthorship W2588396622A5044740469 @default.
• W2588396622 hasAuthorship W2588396622A5052863636 @default.
• W2588396622 hasAuthorship W2588396622A5054197629 @default.
• W2588396622 hasAuthorship W2588396622A5054830306 @default.
• W2588396622 hasAuthorship W2588396622A5076205303 @default.
• W2588396622 hasAuthorship W2588396622A5082899595 @default.
• W2588396622 hasAuthorship W2588396622A5083767342 @default.
• W2588396622 hasBestOaLocation W25883966222 @default.
• W2588396622 hasConcept C126322002 @default.
• W2588396622 hasConcept C142724271 @default.
• W2588396622 hasConcept C164705383 @default.
• W2588396622 hasConcept C203092338 @default.
• W2588396622 hasConcept C204787440 @default.
• W2588396622 hasConcept C207200792 @default.
• W2588396622 hasConcept C27081682 @default.
• W2588396622 hasConcept C2775935837 @default.
• W2588396622 hasConcept C2776002628 @default.
• W2588396622 hasConcept C2777387769 @default.
• W2588396622 hasConcept C2778198053 @default.
• W2588396622 hasConcept C2778797674 @default.
• W2588396622 hasConcept C2780185194 @default.
• W2588396622 hasConcept C535046627 @default.
• W2588396622 hasConcept C68731436 @default.
• W2588396622 hasConcept C71924100 @default.
• W2588396622 hasConcept C84393581 @default.
• W2588396622 hasConceptScore W2588396622C126322002 @default.

• next